HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In response to DNA damage, p53 undergoes post-translational modifications (including acetylation) that are critical for its transcriptional activity. However, the mechanism by which p53 acetylation is regulated is still unclear. Here, we describe an essential role for HLA-B-associated transcript 3 (Bat3)/Scythe in controlling the acetylation of p53 required for DNA damage responses. Depletion of Bat3 from human and mouse cells markedly impairs p53-mediated transactivation of its target genes Puma and p21. Although DNA damage-induced phosphorylation, stabilization, and nuclear accumulation of p53 are not significantly affected by Bat3 depletion, p53 acetylation is almost completely abolished. Bat3 forms a complex with p300, and an increased amount of Bat3 enhances the recruitment of p53 to p300 and facilitates subsequent p53 acetylation. In contrast, Bat3-depleted cells show reduced p53–p300 complex formation and decreased p53 acetylation. Furthermore, consistent with our in vitro findings, thymocytes from Bat3-deficient mice exhibit reduced induction of puma and p21, and are resistant to DNA damage-induced apoptosis in vivo. Our data indicate that Bat3 is a novel and essential regulator of p53-mediated responses to genotoxic stress, and that Bat3 controls DNA damage-induced acetylation of p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 2×
“resulting in cell cycle arrest, DNA repair, senescence, or apoptosis (Levine 1997; Vogelstein et al. 2000; Vousden and Lu 2002).”
BackgroundLane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · cited 1×
“The tumor suppressor protein p53 is a key guardian of genomic stability (Lane 1992).”
BackgroundMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 2×
“…such as Mdm2/Hdm2 (human Mdm2) (Iwakuma and Lozano 2003), COP1 (Dornan et al. 2004), Pirh2 (Leng et al. 2003), and ARF-BP1 (Chen et al. 2005) because these molecules promote ubiquitination and proteasome-mediated degradation of p53 (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“…such as Mdm2/Hdm2 (human Mdm2) (Iwakuma and Lozano 2003), COP1 (Dornan et al. 2004), Pirh2 (Leng et al. 2003), and ARF-BP1 (Chen et al. 2005) because these molecules promote ubiquitination and proteasome-mediated degradation of p53 (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).”
Backgroundp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 1×
“We confirmed this finding in another set of cell lines, p53 wild-type and p53-null HCT116 cells (Bunz et al. 1998).”
ResultDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 1×
“DNA damage-induced phosphorylation by ATM, Chk2, DNA-PK, or ATR of serine and threonine residues within the p53 N terminus prevents Mdm2 binding and subsequent ubiquitin-mediated degradation of p53 (Shieh et al. 1997; Tibbetts et al. 1999; Hirao et al. 2000).”
BackgroundOncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · cited 2×
“…such as Mdm2/Hdm2 (human Mdm2) (Iwakuma and Lozano 2003), COP1 (Dornan et al. 2004), Pirh2 (Leng et al. 2003), and ARF-BP1 (Chen et al. 2005) because these molecules promote ubiquitination and proteasome-mediated degradation of p53 (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).”
BackgroundCBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778 · cited 2×
“Since dysregulation of the p300–p53 pathway has been observed in multiple cancers (Goodman and Smolik 2000) and a biallelic inactivating mutation of Bat3 has been found in a colon cancer cell line (Ivanov et al.”
Backgroundp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Research works printed but not linked: 49
- 10.1038/nsb0901-730 · DOI
- 10.1093/nar/19.9.2499 · DOI · Paper page
- 10.1046/j.1432-1327.2001.02225.x · DOI · Paper page
- 10.1016/S0092-8674(00)80304-9 · DOI · Paper page
- 10.1038/nsb0901-756 · DOI
- 10.1073/pnas.87.6.2374 · DOI · Paper page
- 10.1016/S0955-0674(03)00003-6 · DOI · Paper page
- 10.1016/j.cell.2005.03.037 · DOI · Paper page
- 10.1091/mbc.E03-03-0139 · DOI
- 10.1128/MCB.25.23.10329-10337.2005 · DOI
- 10.1038/nature02514 · DOI · Paper page
- 10.1128/MCB.24.15.6728-6741.2004 · DOI · Paper page
- 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
- Fojta,, 2004, Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function, Eur. J. Biochem., 271, 3865, 10.1111/j.1432-1033.2004.04323.x · DOI
- 10.1093/emboj/19.4.589 · DOI · Paper page
- 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
- 10.1126/science.287.5459.1824 · DOI · Paper page
- 10.1074/jbc.M106643200 · DOI · Paper page
- 10.1016/S1097-2765(00)80463-3 · DOI · Paper page
- 10.1093/emboj/20.6.1331 · DOI · Paper page
- Ivanov, I. Lo, K.C. Hawthorn, L. Cowell, J.K. Ionov, Y. (2006) Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells. Oncogene, Epub November 6, 2006. DOI: 10.1038/sj.onc.1210098. · DOI
- Iwakuma,, 2003, MDM2, an introduction, Mol. Cancer Res., 1, 993
- 10.1016/S1535-6108(03)00244-7 · DOI · Paper page
- 10.1038/sj.onc.1207536 · DOI
- 10.1093/nar/29.9.1989 · DOI
- 10.1016/j.cell.2006.01.044 · DOI · Paper page
- 10.1016/j.bbrc.2004.09.006 · DOI
- 10.1016/S0092-8674(03)00193-4 · DOI · Paper page
- 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- 10.1038/42981 · DOI · Paper page
- Liu,, 2004, Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain, Cancer Biol. Ther., 3, 1102, 10.4161/cbt.3.11.1189 · DOI
- 10.1073/pnas.0308762101 · DOI · Paper page
- 10.1006/bbrc.2001.5701 · DOI
- 10.1074/jbc.273.37.24009 · DOI
- 10.1128/MCB.22.19.6797-6808.2002 · DOI
- 10.1016/j.molcel.2004.09.032 · DOI · Paper page
- 10.1128/MCB.22.10.3509-3517.2002 · DOI · Paper page
- 10.1038/sj.onc.1207324 · DOI
- 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- 10.1128/MCB.20.22.8458-8467.2000 · DOI · Paper page
- 10.1126/science.2911734 · DOI · Paper page
- 10.1093/emboj/17.21.6135 · DOI
- 10.1093/emboj/18.20.5486 · DOI
- 10.1093/emboj/20.5.1033 · DOI
- 10.1038/nrc864 · DOI · Paper page
- 10.1074/jbc.M409522200 · DOI
- 10.1177/41.1.7678025 · DOI · Paper page
- 10.1074/jbc.M307049200 · DOI
- 10.1038/382319a0 · DOI · Paper page
Cited by
Common 5p15.33 and 6p21.33 variants influence lung cancer risk
Wang, Y., Broderick, P., Webb, E., Wu, X., Vijayakrishnan, J., Matakidou, A., Qureshi, M., Dong, Q., Gu, X., Chen, W. V., et al. (2008) · Nature Genetics · doi:10.1038/ng.273 · Cited by 551
Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.-L., & Zhao, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.028 · Cited by 415
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394
Self-citationPogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.010 · Cited by 374
The BAG proteins: a ubiquitous family of chaperone regulators
Kabbage, M., & Dickman, M. B. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7535-2 · Cited by 308
Metadata
- Authors
- Sasaki, T., Gan, E. C., Wakeham, A., Kornbluth, S., Mak, T. W., & Okada, H.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-04-01
- Volume
- 21
- Issue
- 7
- Pages
- 848-861
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2130076355
- Cited by
- 128
- References
- 18
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. https://app.cochat.ai/papers/10.1101/gad.1534107
- The paper
- Sasaki, T., Gan, E. C., Wakeham, A., Kornbluth, S., Mak, T. W., & Okada, H. (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes & Development. https://doi.org/10.1101/gad.1534107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.